Clinica Sierra Vista
Clinica Sierra Vista was paid $23.33M by Medicaid between Jan 2018 and Dec 2024, across 122 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 98% of everything it billed.
BAKERSFIELD, CA 93301
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,730 | $2.04M | |
| 2019 | 21,928 | $2.49M | |
| 2020 | 44,356 | $3.69M | |
| 2021 | 125,187 | $10.51M | |
| 2022 | 40,517 | $3.57M | |
| 2023 | 6,802 | $404K | |
| 2024incomplete | 5,926 | $623K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 98% | 117,605 | 101,386 | $22.87M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,902 | 2,868 | $100K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 37,824 | 32,633 | $45K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 1,380 | 1,260 | $40K |
| V2020 | Frames, purchases | <1% | 2,332 | 2,332 | $36K |
| 0012A | <1% | 560 | 559 | $35K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 9,748 | 8,405 | $33K |
| 0011A | <1% | 702 | 699 | $32K | |
| 92015 | Determination of refractive state | <1% | 3,247 | 3,219 | $23K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,595 | 1,593 | $17K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13,827 | 11,809 | $14K |
| 0002A | <1% | 180 | 180 | $12K |
110 more codes
| 0064A | <1% | 191 | $11K | |
| 0001A | <1% | 134 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,279 | $6K |
| 92341 | <1% | 362 | $6K | |
| 0004A | <1% | 89 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,253 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 442 | $4K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 94 | $3K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 192 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 686 | $3K |
| 0072A | <1% | 42 | $3K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,140 | $2K |
| 0054A | <1% | 27 | $2K | |
| 0071A | <1% | 27 | $2K | |
| 90750 | <1% | 159 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,087 | $1K |
| 90688 | <1% | 281 | $1K | |
| 99201 | <1% | 661 | $967.70 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 906 | $930.44 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 717 | $895.20 |
| 90677 | <1% | 15 | $872.46 | |
| 90739 | <1% | 15 | $757.73 | |
| 90837 | Psychotherapy session, about an hour | <1% | 106 | $659.85 |
| 90686 | <1% | 849 | $588.21 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 494 | $566.44 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 326 | $549.45 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,136 | $481.68 |
| 90791 | Psychiatric diagnostic evaluation | <1% | 708 | $481.02 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,317 | $262.50 |
| 99205 | Prolong outpt/office vis | <1% | 18 | $248.10 |
| 81002 | <1% | 7,318 | $237.36 | |
| 82962 | <1% | 1,035 | $195.04 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 157 | $148.75 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,950 | $140.65 |
| 90698 | <1% | 718 | $108.00 | |
| 81025 | <1% | 2,510 | $96.15 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $94.48 |
| 90696 | <1% | 26 | $93.70 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,130 | $90.60 |
| 99188 | <1% | 52 | $89.16 | |
| 90651 | <1% | 163 | $63.00 | |
| 90744 | <1% | 586 | $54.00 | |
| 90700 | <1% | 35 | $54.00 | |
| 85018 | <1% | 499 | $53.10 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 994 | $48.93 |
| 2022F | <1% | 167 | $42.44 | |
| 92134 | <1% | 16 | $31.93 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 278 | $31.04 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 59 | $30.95 |
| 90657 | <1% | 29 | $27.00 | |
| 90734 | <1% | 73 | $18.00 | |
| 90633 | <1% | 281 | $9.00 | |
| 99173 | <1% | 154 | $4.03 | |
| 3078F | <1% | 1,236 | $0.01 | |
| Z6410 | 0% | 1,729 | $0.00 | |
| Z6204 | 0% | 1,294 | $0.00 | |
| 90732 | 0% | 25 | $0.00 | |
| 91301 | 0% | 213 | $0.00 | |
| Z1034 | 0% | 4,604 | $0.00 | |
| 91306 | 0% | 15 | $0.00 | |
| Z6404 | 0% | 48 | $0.00 | |
| 3074F | 0% | 1,428 | $0.00 | |
| Z6406 | 0% | 1,705 | $0.00 | |
| 90680 | 0% | 487 | $0.00 | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 270 | $0.00 |
| Z1032 | 0% | 353 | $0.00 | |
| 3075F | 0% | 32 | $0.00 | |
| 3079F | 0% | 248 | $0.00 | |
| 93000 | 0% | 80 | $0.00 | |
| 90716 | 0% | 248 | $0.00 | |
| 99381 | 0% | 275 | $0.00 | |
| 99384 | 0% | 68 | $0.00 | |
| 3044F | 0% | 12 | $0.00 | |
| Z6402 | 0% | 1,176 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 17 | $0.00 |
| 92551 | 0% | 118 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 15 | $0.00 |
| 99385 | 0% | 13 | $0.00 | |
| 99460 | 0% | 75 | $0.00 | |
| Z1038 | 0% | 110 | $0.00 | |
| 99383 | 0% | 149 | $0.00 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 0% | 15 | $0.00 |
| 3080F | 0% | 14 | $0.00 | |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 33 | $0.00 |
| J3490 | Unclassified drugs | 0% | 20 | $0.00 |
| Z7610 | 0% | 13 | $0.00 | |
| 3072F | 0% | 19 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 12 | $0.00 |
| 90707 | 0% | 247 | $0.00 | |
| Z6414 | 0% | 624 | $0.00 | |
| 90670 | 0% | 944 | $0.00 | |
| 90715 | 0% | 232 | $0.00 | |
| Z6208 | 0% | 624 | $0.00 | |
| Z6400 | 0% | 1,291 | $0.00 | |
| Z6300 | 0% | 1,185 | $0.00 | |
| Z6308 | 0% | 618 | $0.00 | |
| Z6304 | 0% | 1,369 | $0.00 | |
| Z6200 | 0% | 1,325 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 307 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 182 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 117 | $0.00 |
| Z6302 | 0% | 29 | $0.00 | |
| 91300 | 0% | 12 | $0.00 | |
| 90746 | 0% | 29 | $0.00 | |
| 3077F | 0% | 51 | $0.00 | |
| 99238 | Hospital discharge day management, 30 minutes or less | 0% | 25 | $0.00 |
| 99382 | 0% | 33 | $0.00 | |
| 90736 | 0% | 14 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 12 | $0.00 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Clinica Sierra Vista | Bakersfield, CA | $64.97M |
| Clinica Sierra Vista | Bakersfield, CA | $33.77M |
| Clinica Sierra Vista | Lamont, CA | $29.67M |
| Clinica Sierra Vista | Fresno, CA | $23.94M |
| Clinica Sierra Vista | Fresno, CA | $23.08M |
| Clinica Sierra Vista | Bakersfield, CA | $21.29M |
| Clinica Sierra Vista | Bakersfield, CA | $17.29M |
| Clinica Sierra Vista | Bakersfield, CA | $14.66M |
| Clinica Sierra Vista | Fresno, CA | $14.10M |
| Clinica Sierra Vista | Arvin, CA | $14.09M |
| Clinica Sierra Vista | Lebec, CA | $7.87M |
| Clinica Sierra Vista | Delano, CA | $7.36M |
| Clinica Sierra Vista | Bakersfield, CA | $6.28M |
| Clinica Sierra Vista | Bakersfield, CA | $5.91M |
| Clinica Sierra Vista | Fresno, CA | $5.86M |
| Clinica Sierra Vista | Fresno, CA | $5.78M |
| Clinica Sierra Vista | Bakersfield, CA | $5.55M |
| Clinica Sierra Vista | Bakersfield, CA | $4.15M |
| Clinica Sierra Vista | Fresno, CA | $3.75M |
| Clinica Sierra Vista | Fresno, CA | $3.47M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.